Also relevant is the recent finding that metformin’s effect as a cancer therapeutic is partially mediated by inhibition of mTOR, raising the question of whether metformin may influence the positive effects of Akt-mTOR pathway activation on muscle mass [20]. Here, MTOR is linked to cancer.